A phase I-II study of high-dose recombinant human interleukin-2 in disseminated renal-cell carcinoma
- 1 January 1988
- journal article
- research article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 4 (3) , 207-209
- https://doi.org/10.1002/ssu.2980040314
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Human normal CTL clones: Generation and propertiesInternational Journal of Cancer, 1983